Please login to the form below

Not currently logged in
Email:
Password:

MHP Communications adds two directors to health unit

Timothy Goodman and Stephanie Snow join

MHP Communications Timothy GoodmanUK-based public relations and corporate communications consultancy MHP Communications has added two new directors to its health division.

Timothy Goodman (pictured right) brings 18 years of global pharmaceutical communications and policy advocacy experience to the consultancy, joining MHP from Edelman's London-based health group.

Prior to this, Goodman spent 14 years with Pfizer during which time he served as speechwriter to the chairman and chief executive officer, assistant director of global policy and corporate affairs director for Pfizer Chile.

MHP Communications Stephanie SnowAlso joining MHP is Stephanie Snow (pictured left), who brings over 20 years of pharmaceutical and healthcare communications expertise to the health director role, with particular experience in disease awareness campaigns, regulatory milestones, market access programmes and crisis preparation.

Snow has held client-side communications roles at Pfizer and GSK, and has also served as agencies Hill & Knowlton, Ketchum and most recently Munro & Forster, where she was of head of its healthcare practice.

Rachel Rowson, head of MHP Health, said: “The critical issues in healthcare communications are multi-faceted, and the experience and expertise both Tim and Stephanie bring will enhance what we can offer to clients globally and by using PR and the media.

“There is an increasing expectation among clients for advisors who are both specialists, but can also seamlessly bled all of their communications needs; Tim and Stephanie will help us to deliver this.”

11th October 2016

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Branding Science

We are Branding Science Partners in thinking which inspires change in healthcare Branding Science are an award-winning global pharmaceutical market...

Latest intelligence

The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...
PRO
Integrating patient reported outcomes into clinical trials
How capturing the patient voice is unlocking medicines’ commercial potential...

Infographics